629 related articles for article (PubMed ID: 16201093)
21. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis.
Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Yokosuka O
World J Gastroenterol; 2015 Aug; 21(29):8894-902. PubMed ID: 26269679
[TBL] [Abstract][Full Text] [Related]
22. [Study on the relation between hemodynamics of portal system and cirrhosis portal hypertension].
Lu HY; Tian XL; Zhang CX; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):306-7. PubMed ID: 19403033
[No Abstract] [Full Text] [Related]
23. Percutaneous transhepatic portography. III. Relationships between portosystemic collaterals and portal pressure in cirrhosis.
Burcharth F; Sørensen TI; Andersen B
AJR Am J Roentgenol; 1979 Dec; 133(6):1119-22. PubMed ID: 116503
[TBL] [Abstract][Full Text] [Related]
24. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration.
Akahane T; Iwasaki T; Kobayashi N; Tanabe N; Takahashi N; Gama H; Ishii M; Toyota T
Am J Gastroenterol; 1997 Jun; 92(6):1026-30. PubMed ID: 9177524
[TBL] [Abstract][Full Text] [Related]
25. Ultrasonic evaluation of portosystemic collateral circulation in portal hypertension.
Sheth SG; Amarapurkar DN; Chopra KB; Mani SA; Mehta PJ
J Assoc Physicians India; 1996 Aug; 44(8):537-9. PubMed ID: 9251426
[TBL] [Abstract][Full Text] [Related]
26. Eradication of esophageal varices by sclerotherapy combined with argon plasma coagulation: Effect of portal hemodynamics and longitudinal clinical course.
Kondo T; Maruyama H; Kiyono S; Sekimoto T; Shimada T; Takahashi M; Okugawa H; Yokosuka O; Kawahira H; Yamaguchi T
Dig Endosc; 2016 Mar; 28(2):152-61. PubMed ID: 26505617
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study of radioisotopic splenoportography in portal hypertension].
Yokoyama Y
Nihon Geka Gakkai Zasshi; 1990 Feb; 91(2):234-45. PubMed ID: 2325608
[TBL] [Abstract][Full Text] [Related]
28. [Doppler-duplex ultrasonography in the diagnosis of cavernous portal vein].
Perisić M; Djulafić Dj; Sagić D; Grbić R
Srp Arh Celok Lek; 1998; 126(9-10):368-73. PubMed ID: 9863409
[TBL] [Abstract][Full Text] [Related]
29. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure.
Kayacetin E; Efe D; Doğan C
J Gastroenterol; 2004 Jul; 39(7):661-7. PubMed ID: 15293137
[TBL] [Abstract][Full Text] [Related]
30. Portal vein thrombosis following sclerotherapy.
Qureshi H; Siddiqui K; Ahmad R; Maher M; Ali A; Ahmed W; Zuberi SJ
Hepatogastroenterology; 1992 Oct; 39(5):427-8. PubMed ID: 1459524
[TBL] [Abstract][Full Text] [Related]
31. The effects of chronic endoscopic variceal sclerotherapy on portal pressure in cirrhotics.
Korula J; Ralls P
Gastroenterology; 1991 Sep; 101(3):800-5. PubMed ID: 1860642
[TBL] [Abstract][Full Text] [Related]
32. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization.
Watanabe K; Kimura K; Matsutani S; Ohto M; Okuda K
Gastroenterology; 1988 Aug; 95(2):434-40. PubMed ID: 3391371
[TBL] [Abstract][Full Text] [Related]
33. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices.
Matsumoto A; Hamamoto N; Nomura T; Hongou Y; Arisaka Y; Morikawa H; Hirata I; Katsu K
Am J Gastroenterol; 1999 Mar; 94(3):643-9. PubMed ID: 10086645
[TBL] [Abstract][Full Text] [Related]
34. [Determination of blood cell count and spleen size in patients with liver cirrhosis submitted to endoscopic sclerotherapy for esophageal varices].
Wysocki A; Poźniczek M; Budzyński A
Przegl Lek; 1999; 56(10):653-5. PubMed ID: 10695379
[TBL] [Abstract][Full Text] [Related]
35. Sclerotherapy of esophageal varices: an endoscopic and portographic study.
Söderlund C; Backman L; Erwald R; Forsgren L; Marions O; Wiechel KL
Hepatology; 1984; 4(5):877-84. PubMed ID: 6332767
[TBL] [Abstract][Full Text] [Related]
36. Qualitative hepatic venous Doppler sonography versus portal flowmetry in predicting the severity of esophageal varices in hepatitis C cirrhosis.
Gorka W; al Mulla A; al Sebayel M; Altraif I; Gorka TS
AJR Am J Roentgenol; 1997 Aug; 169(2):511-5. PubMed ID: 9242766
[TBL] [Abstract][Full Text] [Related]
37. Venous complications of sclerotherapy for esophageal varices.
Hunter GC; Steinkirchner T; Burbige EJ; Guernsey JM; Putnam CW
Am J Surg; 1988 Dec; 156(6):497-501. PubMed ID: 3264465
[TBL] [Abstract][Full Text] [Related]
38. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure.
Taourel P; Blanc P; Dauzat M; Chabre M; Pradel J; Gallix B; Larrey D; Bruel JM
Hepatology; 1998 Oct; 28(4):932-6. PubMed ID: 9755228
[TBL] [Abstract][Full Text] [Related]
39. Influence of long-term injection sclerotherapy on portal venous component of total liver perfusion measured by hepatosplenic radionuclide angiography.
Sauerbruch T; Moser E
Hepatogastroenterology; 1986 Feb; 33(1):17-9. PubMed ID: 3957225
[TBL] [Abstract][Full Text] [Related]
40. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.
Lafortune M; Martinet JP; Denys A; Patriquin H; Dauzat M; Dufresne MP; Colombato L; Pomier-Layrargues G
AJR Am J Roentgenol; 1995 Apr; 164(4):997-1002. PubMed ID: 7726065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
